AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 19-A-02-086.02
We recommend that the State agency refund to the Federal Government $561,937 (Federal share) for claims for top-20 multiple-source…
The recommendation, in the publisher's words
We recommend that the State agency refund to the Federal Government $561,937 (Federal share) for claims for top-20 multiple-source physician-administered drugs that were ineligible for Federal reimbursement.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- May 9, 2019
- Report
- New Jersey Claimed Unallowable Federal Reimbursement for Some Medicaid Physician-Administered Drugs (A-02-16-01012) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Last update received
- October 6, 2026
- Next update expected
- April 13, 2027 (publisher's date)
- Potential savings
- $561,937 (the publisher's figure; not realised savings)
- Publisher topics
- Financial Stewardship, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
- Last update received changed from “April 14, 2026” to “October 6, 2026”. (observed by AuditLine in the publisher's file)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
6 more, of which 6 are open in the publisher's file.
- We recommend that the State agency refund to the Federal Government $7,578,002 (Federal share) for claims for single-source physician-administered drugs that were ineligible for Federal…HHS OIG 19-A-02-086.01 · issued May 9, 2019Open Unimplemented
- We recommend that the State agency work with CMS to determine the unallowable portion of $7,889 (Federal share) for other claims for covered outpatient physician-administered drugs that…HHS OIG 19-A-02-086.03 · issued May 9, 2019Open Unimplemented
- We recommend that the State agency work with CMS to determine whether the remaining $1,109,110 (Federal share) of other physician-administered drug claims could have been invoiced to the…HHS OIG 19-A-02-086.04 · issued May 9, 2019Open Unimplemented
- We recommend that the State agency work with CMS to determine and refund the unallowable portion of Federal reimbursement for physician-administered drugs that were not invoiced for…HHS OIG 19-A-02-086.05 · issued May 9, 2019Open Unimplemented
- We recommend that the State agency develop and implement formal written policies and procedures for its drug rebate program.HHS OIG 19-A-02-086.06 · issued May 9, 2019Open Unimplemented
- We recommend that the State agency strengthen its internal controls to ensure that all physician-administered drugs eligible for rebates are invoiced.HHS OIG 19-A-02-086.07 · issued May 9, 2019Open Unimplemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.